Brief: HBM Healthcare Says Cathay Biotech Raises Capital And Enters Into Major Strategic Collaboration With China Merchants Group
26/06/2023 05:35
June 26 (Reuters) - HBM Healthcare Investments AG
HBMN.S :
* CATHAY BIOTECH RAISES CAPITAL AND ENTERS INTO MAJOR
STRATEGIC
COLLABORATION WITH CHINA MERCHANTS GROUP
* HBM HEALTHCARE INVESTMENTS AG- CAPITAL INCREASE BY CATHAY
BIOTECH IN AMOUNT OF UP TO RMB 6.6 BILLION, WITH NEW SHARES
BEING ACQUIRED BY CMG
Source text for Eikon: ID:nEQ6t7tGHa
Further company coverage: HBMN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HBM Healthcare Investments AG
See all newsSwiss stocks - Factors to watch on October 23
Brief: HBM Healthcare Investments Reports Q1 Profit CHF 238 Million
Brief: HBM Healthcare Investments Posts Profit Of CHF 272 Million
Brief: SK Capital Is Said To Near Deal For Swiss Drug Distributor Swixx That Could Value Co At About 1.5 Billion Euros- Bloomberg News
Brief: Mirum Pharmaceuticals To Acquire HBM Portfolio Company Bluejay Therapeutics